Table 3 VEGF-A rs3025020 and rs3025039 distribution and odds ratio assessment between control and T2DM with mixed complications groups
Parameters | Mixed complications N = 26 | Control # N = 26 | Test | P value | Odds ratio | 95% CI |
|---|---|---|---|---|---|---|
No (%) | No (%) | |||||
rs3025020 genotypes | ||||||
CC* | 12 (46.2) | 18 (69.2) | – | – | Ref (1.0) | |
CT | 11 (42.3) | 8 (30.8) | 1.5 | 0.22 | 2.06 | 0.64–6.63 |
TT | 3 (11.5) | 0 (0.0) | 1.91 | 0.17 | – | – |
rs3025020 alleles | ||||||
C* | 35 (67.3) | 44 (84.6) | ||||
T | 17 (32.7) | 8 (15.4) | 4.27 | 0.04 | 2.67 | 1.03–6.91 |
rs3025039 genotypes | ||||||
CC* | 10 (38.5) | 20 (76.9) | – | – | Ref (1) | |
CT | 12 (46.2) | 5 (19.2) | 6.05 | 0.01 | 4.08 | 1.32–17.44 |
TT | 4 (15.4) | 1 (3.8) | 2.19 | 0.14 | 8.0 | 0.79–81.33 |
rs3025039 alleles | ||||||
C* | 32 (61.5) | 45 (86.5) | Ref (1) | |||
T | 20 (38.5) | 7 (13.5) | 8.45 | 0.004 | 4.02 | 1.52–10.63 |